{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T14:15:21Z","timestamp":1740147321361,"version":"3.37.3"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T00:00:00Z","timestamp":1681257600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T00:00:00Z","timestamp":1681257600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ir J Med Sci"],"published-print":{"date-parts":[[2023,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Heart failure (HF) is the only cardiovascular disease with an ever-increasing incidence.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Aims<\/jats:title>\n                <jats:p>The aim of this study was to assess the predictors of adverse clinical events (CE) and the creation and evaluation of the prognostic value of a novel personalized scoring system in patients with HF.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The study included 113 HF patients (median age 64\u00a0years (IQR 58\u201369); 57.52% male). The new novel prognostic score named GLVC (G, global longitudinal peak strain (GLPS); L, left ventricular diastolic diameter (LVDD); V, oxygen pulse (VO<jats:sub>2<\/jats:sub>\/HR); and C, high sensitivity C-reactive protein (hs-CRP)) was created. The Kaplan\u2013Meier method and log-rank test were used to compare the CE.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Results from final analyses showed that low GLPS (&lt;\u200913.9%, OR\u2009=\u20092.66, 95% CI\u2009=\u20091.01\u20134.30,<jats:italic> p<\/jats:italic>\u2009=\u20090.002), high LVDD (&gt;\u200956\u00a0mm, OR\u2009=\u20092.37, 95% CI\u2009=\u20091.01\u20135.55, <jats:italic>p<\/jats:italic>\u2009=\u20090.045), low oxygen pulse (&lt;\u200910, OR\u2009=\u20092.8, 95% CI\u2009=\u20091.17\u20136.70, <jats:italic>p<\/jats:italic>\u2009=\u20090.019), and high hs-CRP (&gt;\u20092.38\u00a0\u00b5g\/ml, OR\u2009=\u20092.93, 95% CI\u2009=\u20091.31\u20136.54, <jats:italic>p<\/jats:italic>\u2009=\u20090.007) were independent prognostic factors for adverse CE in HF population. All the patients were stratified into a low-risk or high-risk group according to a novel \u201cGLVC\u201d scoring system. The Kaplan\u2013Meier analyses demonstrated that patients in the high-risk group were more predisposed to having higher adverse clinical events compared to patients in the low-risk group.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>A novel and comprehensive personalized \u201cGLVC\u201d scoring system is an easily available and effective tool for predicting the adverse outcomes in HF.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Graphical abstract<\/jats:title>\n                \n              <\/jats:sec>","DOI":"10.1007\/s11845-023-03343-4","type":"journal-article","created":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T03:41:32Z","timestamp":1681270892000},"page":"2713-2726","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The GLVC scoring system: a single-center model for predicting survival and hospitalization in patients with heart failure"],"prefix":"10.1007","volume":"192","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6850-6126","authenticated-orcid":false,"given":"Anna","family":"Chuda-Wietczak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5083-2046","authenticated-orcid":false,"given":"Agata","family":"Sakowicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7855-7261","authenticated-orcid":false,"given":"Agnieszka","family":"Tycinska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8996-4257","authenticated-orcid":false,"given":"Ibadete","family":"Bytyci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6666-3999","authenticated-orcid":false,"given":"Agata","family":"Bielecka-Dabrowa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,4,12]]},"reference":[{"issue":"1","key":"3343_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.15420\/cfr.2016:25:2","volume":"3","author":"G Savarese","year":"2017","unstructured":"Savarese G, Lund LH (2017) Global public health burden of heart failure. Card Fail Rev 3(1):7\u201311. https:\/\/doi.org\/10.15420\/cfr.2016:25:2","journal-title":"Card Fail Rev"},{"key":"3343_CR2","doi-asserted-by":"publisher","first-page":"e56","DOI":"10.1161\/CIR.0000000000000659","volume":"139","author":"EJ Benjamin","year":"2019","unstructured":"Benjamin EJ, Muntner P, Alonso A et al (2019) Heart disease and stroke statistics\u20142019 update: a report from the American Heart Association. Circulation 139:e56\u2013e528. https:\/\/doi.org\/10.1161\/CIR.0000000000000659","journal-title":"Circulation"},{"key":"3343_CR3","doi-asserted-by":"publisher","unstructured":"Chuda A, Banach M, Maciejewski M, Bielecka-Dabrowa A (2022) Role of confirmed and potential predictors of an unfavorable outcome in heart failure in everyday clinical practice. Ir J Med Sci 191(1):213\u2013227. https:\/\/doi.org\/10.1007\/s11845-020-02477-z. Epub 2021 Feb 17. PMID: 33595788; PMCID: PMC8789698","DOI":"10.1007\/s11845-020-02477-z"},{"issue":"12","key":"3343_CR4","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/j.jacc.2013.11.053","volume":"63","author":"AP Ambrosy","year":"2014","unstructured":"Ambrosy AP, Fonarow GC, Butler J et al (2014) The global health and economic burden of hospitalizations for heart failure. J Am Coll Cardiol 63(12):1123\u20131133","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"3343_CR5","doi-asserted-by":"publisher","first-page":"10715","DOI":"10.3390\/ijms160510715","volume":"16","author":"A Bielecka-Dabrowa","year":"2015","unstructured":"Bielecka-Dabrowa A, Gluba-Brz\u00f3zka A, Michalska-Kasiczak M et al (2015) The multi-biomarker approach for heart failure in patients with hypertension. Int J Mol Sci 16(5):10715\u201310733","journal-title":"Int J Mol Sci"},{"key":"3343_CR6","doi-asserted-by":"publisher","first-page":"3068","DOI":"10.1161\/01.CIR.0000039105.49749.6F","volume":"106","author":"DM Lloyd-Jones","year":"2002","unstructured":"Lloyd-Jones DM, Larson MG, Leip EP et al (2002) Lifetime risk for developing congestive heart failure: the Framingham Heart Study. Circulation 106:3068\u20133072","journal-title":"Circulation"},{"key":"3343_CR7","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.ijcard.2016.07.150","volume":"221","author":"A Bielecka-Dabrowa","year":"2016","unstructured":"Bielecka-Dabrowa A et al (2016) Differences in biochemical and genetic biomarkers in patients with heart failure of various etiologies. Int J Cardiol 221:1073\u20131080","journal-title":"Int J Cardiol"},{"issue":"36","key":"3343_CR8","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","volume":"42","author":"T McDonagh","year":"2021","unstructured":"McDonagh T, Metra M, Adamo M et al (2021) ESC Scientific Document Group, 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 42(36):3599\u20133726. https:\/\/doi.org\/10.1093\/eurheartj\/ehab368","journal-title":"Eur Heart J"},{"issue":"6","key":"3343_CR9","doi-asserted-by":"publisher","first-page":"519","DOI":"10.5603\/KP.a2017.0088","volume":"75","author":"A Kap\u0142on-Cie\u015blicka","year":"2017","unstructured":"Kap\u0142on-Cie\u015blicka A, Dro\u017cd\u017c J, Filipiak KJ (2017) Prognostic factors in heart failure \u2014 are they all equally important? Kardiol Pol 75(6):519\u2013526","journal-title":"Kardiol Pol"},{"key":"3343_CR10","unstructured":"Committee of the New York Heart Association (1994) Nomenclature and criteria for diagnosis of diseases of the heart and great vessels. 9th ed. Boston: Little, Brown & Co. p 253\u2013256"},{"issue":"11\u201312","key":"3343_CR11","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1111\/j.1365-2036.2005.02691","volume":"22","author":"E Cholongitas","year":"2005","unstructured":"Cholongitas E, Papatheodoridis GV, Vangeli M et al (2005) Systematic review: the model for end-stage liver disease\u2013should it replace Child\u2013Pugh\u2019s classification for assessing prognosis in cirrhosis? Aliment Pharmacol Ther 22(11\u201312):1079\u20131089. https:\/\/doi.org\/10.1111\/j.1365-2036.2005.02691","journal-title":"Aliment Pharmacol Ther"},{"issue":"11","key":"3343_CR12","doi-asserted-by":"publisher","first-page":"825","DOI":"10.7326\/0003-4819-158-11-201306040-00007","volume":"158","author":"PE Stevens","year":"2013","unstructured":"Stevens PE, Levin A, Kidney disease: improving global outcomes chronic kidney disease guideline development work group members (2013) Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med 158(11):825\u2013830. https:\/\/doi.org\/10.7326\/0003-4819-158-11-201306040-00007","journal-title":"Ann Intern Med"},{"issue":"5","key":"3343_CR13","first-page":"303","volume":"5","author":"D DuBois","year":"1989","unstructured":"DuBois D, DuBois EF (1989) A formula to estimate the approximate surface area if height and weight be known. 1916. Nutrition 5(5):303\u2013311","journal-title":"Nutrition"},{"key":"3343_CR14","doi-asserted-by":"publisher","unstructured":"Rudski LG, Lai WW, Afilalo J et al (2010) Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr 23 685\u2013713; quiz 786. https:\/\/doi.org\/10.1016\/j.echo.2010.05.010","DOI":"10.1016\/j.echo.2010.05.010"},{"key":"3343_CR15","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1093\/ehjci\/jev014","volume":"16","author":"RM Lang","year":"2015","unstructured":"Lang RM, Badano LP, Mor-Avi V et al (2015) Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J: Cardiovasc Imaging 16:233\u2013270. https:\/\/doi.org\/10.1093\/ehjci\/jev014","journal-title":"Eur Heart J: Cardiovasc Imaging"},{"key":"3343_CR16","unstructured":"Tanita MC-780MA user manual. https:\/\/www.manua.ls\/tanita\/mc-780ma\/manual?p=26. Accessed 19 Jan 2021"},{"key":"3343_CR17","doi-asserted-by":"publisher","first-page":"S49","DOI":"10.1164\/arrd.1984.129.2P2.S49","volume":"129","author":"JE Hansen","year":"1984","unstructured":"Hansen JE, Sue DY, Wasserman K (1984) Predicted values for clinical exercise testing. Am Rev Respir Dis 129:S49\u2013S55","journal-title":"Am Rev Respir Dis"},{"key":"3343_CR18","first-page":"919","volume":"132","author":"GH Guyatt","year":"1985","unstructured":"Guyatt GH, Sullivan MJ, Thompson PJ et al (1985) The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure. Can Med Assoc J 132:919\u2013923","journal-title":"Can Med Assoc J"},{"key":"3343_CR19","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/S0735-1097(00)00531-3","volume":"35","author":"CP Green","year":"2000","unstructured":"Green CP, Porter CB, Bresnahan DR, Spertus JA (2000) Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure. J Am CollCardiol 35:1245\u20131255","journal-title":"J Am CollCardiol"},{"key":"3343_CR20","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1111\/ejhf.32","volume":"16","author":"U Sartipy","year":"2014","unstructured":"Sartipy U, Dahlstr\u00f6m U, Edner M, Lund LH (2014) Predicting survival in heart failure: validation of the MAGGIC heart failure risk score in 51,043 patients from the Swedish Heart Failure Registry. Eur J Heart Fail 16:173\u2013179","journal-title":"Eur J Heart Fail"},{"key":"3343_CR21","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1161\/CIRCULATIONAHA.105.584102","volume":"113","author":"WC Levy","year":"2006","unstructured":"Levy WC, Mozaffarian D, Linker DT et al (2006) The Seattle Heart Failure Model: prediction of survival in heart failure. Circulation 113:1424\u20131433","journal-title":"Circulation"},{"key":"3343_CR22","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.jacc.2009.04.061","volume":"54","author":"G-Y Cho","year":"2009","unstructured":"Cho G-Y, Marwick TH, Kim H-S et al (2009) Global 2-dimensional strain as a new prognosticator in patients with heart failure. J Am CollCardiol 54:618\u2013624. https:\/\/doi.org\/10.1016\/j.jacc.2009.04.061","journal-title":"J Am CollCardiol"},{"key":"3343_CR23","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1161\/CIRCIMAGING.109.910893","volume":"3","author":"J Nahum","year":"2010","unstructured":"Nahum J, Bensaid A, Dussault C et al (2010) Impact of longitudinal myocardial deformation on the prognosis of chronic heart failure patients. Circ Cardiovasc Imaging 3:249\u2013256. https:\/\/doi.org\/10.1161\/CIRCIMAGING.109.910893","journal-title":"Circ Cardiovasc Imaging"},{"key":"3343_CR24","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1002\/ehf2.12159","volume":"4","author":"J Buggey","year":"2017","unstructured":"Buggey J, Alenezi F, Yoon HJ et al (2017) Left ventricular global longitudinal strain in patients with heart failure with preserved ejection fraction: outcomes following an acute heart failure hospitalization. ESC Heart Fail 4:432\u2013439. https:\/\/doi.org\/10.1002\/ehf2.12159","journal-title":"ESC Heart Fail"},{"key":"3343_CR25","doi-asserted-by":"publisher","unstructured":"Kaufmann D, Szwoch M, Kwiatkowska J et al (2019) Global longitudinal strain can predict heart failure exacerbation in stable outpatients with ischemic left ventricular systolic dysfunction. PLoS One 14(12):e0225829. https:\/\/doi.org\/10.1371\/journal.pone.0225829. PMID: 31790492; PMCID: PMC6886774","DOI":"10.1371\/journal.pone.0225829"},{"issue":"14","key":"3343_CR26","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1016\/j.jacc.2011.06.038","volume":"58","author":"J Gorcsan","year":"2011","unstructured":"Gorcsan J, Tanaka H (2011) Echocardiographic assessment of myocardial strain. J Am CollCardiol 58(14):1401\u20131413. https:\/\/doi.org\/10.1016\/j.jacc.2011.06.038. [PubMed] [CrossRef] [Google Scholar]","journal-title":"J Am CollCardiol"},{"key":"3343_CR27","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1161\/CIRCIMAGING.109.862334","volume":"2","author":"T Stanton","year":"2009","unstructured":"Stanton T, Leano R, Marwick TH (2009) Prediction of all-cause mortality from global longitudinal speckle strain. Circ Cardiovasc Imaging 2:356\u2013364. https:\/\/doi.org\/10.1161\/CIRCIMAGING.109.862334","journal-title":"Circ Cardiovasc Imaging"},{"key":"3343_CR28","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/j.echo.2010.07.019","volume":"23","author":"A Mignot","year":"2010","unstructured":"Mignot A, Donal E, Zaroui A et al (2010) Global longitudinal strain as a major predictor of cardiac events in patients with depressed left ventricular function: a multicenter study. J Am SocEchocardiogr 23:1019\u20131024. https:\/\/doi.org\/10.1016\/j.echo.2010.07.019. [PubMed] [CrossRef] [Google Scholar]","journal-title":"J Am SocEchocardiogr"},{"key":"3343_CR29","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1002\/clc.22662","volume":"40","author":"MM Kansal","year":"2017","unstructured":"Kansal MM, Mansour IN, Ismail S et al (2017) Left ventricular global longitudinal strain predicts mortality and heart failure admissions in African American patients. Clin Cardiol 40:314\u2013321. https:\/\/doi.org\/10.1002\/clc.22662","journal-title":"Clin Cardiol"},{"key":"3343_CR30","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1161\/CIRCIMAGING.111.970434","volume":"5","author":"M Bertini","year":"2012","unstructured":"Bertini M, Ng ACT, Antoni ML et al (2012) Global longitudinal strain predicts long-term survival in patients with chronic ischemic cardiomyopathy. Circ Cardiovasc Imaging 5:383\u2013391. https:\/\/doi.org\/10.1161\/CIRCIMAGING.111.970434","journal-title":"Circ Cardiovasc Imaging"},{"key":"3343_CR31","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.jacc.2012.09.035","volume":"61","author":"P Thavendiranathan","year":"2013","unstructured":"Thavendiranathan P, Grant AD, Negishi T et al (2013) Reproducibility of echocardiographic techniques for sequential assessment of left ventricular ejection fraction and volumes: application to patients undergoing cancer chemotherapy. J Am Coll Cardiol 61:77\u201384","journal-title":"J Am Coll Cardiol"},{"key":"3343_CR32","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/0002-9149(93)90883-E","volume":"72","author":"TH Lee","year":"1993","unstructured":"Lee TH, Hamilton MA, Stevenson LW et al (1993) Impact of left ventricular cavity size on survival in advanced heart failure. Am J Cardiol 72:672\u2013676","journal-title":"Am J Cardiol"},{"key":"3343_CR33","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.cardfail.2004.06.434","volume":"11","author":"J Watanabe","year":"2005","unstructured":"Watanabe J, Shiba N, Shinozaki T et al (2005) Prognostic value of plasma brain natriuretic peptide combined with left ventricular dimensions in predicting sudden death of patients with chronic heart failure. J Card Fail 11:50\u201355","journal-title":"J Card Fail"},{"issue":"5","key":"3343_CR34","doi-asserted-by":"publisher","first-page":"e001193","DOI":"10.1161\/JAHA.114.001193","volume":"3","author":"K Narayanan","year":"2014","unstructured":"Narayanan K, Reinier K, Teodorescu C et al (2014) Left ventricular diameter and risk stratification for sudden cardiac death. J Am Heart Assoc 3(5):e001193. https:\/\/doi.org\/10.1161\/JAHA.114.001193","journal-title":"J Am Heart Assoc"},{"key":"3343_CR35","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1136\/hrt.78.6.572","volume":"78","author":"A Cohen-Solal","year":"1997","unstructured":"Cohen-Solal A, Barnier P, Pessione F et al (1997) Comparison of the long-term prognostic value of peak exercise oxygen pulse and peak oxygen uptake in patients with chronic heart failure. Heart 78:572\u2013576","journal-title":"Heart"},{"key":"3343_CR36","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1053\/euhj.2001.2966","volume":"23","author":"A Cohen-Solal","year":"2002","unstructured":"Cohen-Solal A, Tabet JY, Logeart D et al (2002) A non-invasively determined surrogate of cardiac power (\u201ccirculatory power\u201d) at peak exercise is a powerful prognostic factor in chronic heart failure. Eur Heart J 23:806\u2013814","journal-title":"Eur Heart J"},{"issue":"5","key":"3343_CR37","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.amjcard.2003.11.023","volume":"93","author":"CJ Lavie","year":"2004","unstructured":"Lavie CJ, Milani RV, Mehra MR (2004) Peak exercise oxygen pulse and prognosis in chronic heart failure. Am J Cardiol 93(5):588\u2013593. https:\/\/doi.org\/10.1016\/j.amjcard.2003.11.023. PMID: 14996584","journal-title":"Am J Cardiol"},{"key":"3343_CR38","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.ijcard.2018.01.119","volume":"257","author":"P Moliner","year":"2018","unstructured":"Moliner P, Lup\u00f3n J, Barallat J et al (2018) Bio-profiling and bio-prognostication of chronic heart failure with mid-range ejection fraction. Int J Cardiol 257:188\u2013192","journal-title":"Int J Cardiol"},{"issue":"1","key":"3343_CR39","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1093\/cvr\/cvz198","volume":"116","author":"P Pellicori","year":"2020","unstructured":"Pellicori P, Zhang J, Cuthbert J et al (2020) High-sensitivity C-reactive protein in chronic heart failure: patient characteristics, phenotypes, and mode of death. Cardiovasc Res 116(1):91\u2013100. https:\/\/doi.org\/10.1093\/cvr\/cvz198. PMID: 31350553","journal-title":"Cardiovasc Res"},{"key":"3343_CR40","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1161\/CIRCULATIONAHA.104.508465","volume":"112","author":"IS Anand","year":"2005","unstructured":"Anand IS, Latini R, Florea VG et al (2005) C-reactive protein in heart failure: prognostic value and the effect of valsartan. Circulation 112:1428\u20131434","journal-title":"Circulation"},{"key":"3343_CR41","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1002\/ejhf.104","volume":"16","author":"L Koller","year":"2014","unstructured":"Koller L, Kleber M, Goliasch G et al (2014) C-reactive protein predicts mortality in patients referred for coronary angiography and symptoms of heart failure with preserved ejection fraction. Eur J Heart Fail 16:758\u2013766","journal-title":"Eur J Heart Fail"},{"key":"3343_CR42","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.cardfail.2008.10.030","volume":"15","author":"JP Ara\u00fajo","year":"2009","unstructured":"Ara\u00fajo JP, Louren\u00e7o P, Azevedo A et al (2009) Prognostic value of high-sensitivity C-reactive protein in heart failure: a systematic review. J Card Fail 15:256\u2013266","journal-title":"J Card Fail"}],"container-title":["Irish Journal of Medical Science (1971 -)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-023-03343-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11845-023-03343-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-023-03343-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,2]],"date-time":"2023-12-02T03:20:59Z","timestamp":1701487259000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11845-023-03343-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,12]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["3343"],"URL":"https:\/\/doi.org\/10.1007\/s11845-023-03343-4","relation":{},"ISSN":["0021-1265","1863-4362"],"issn-type":[{"type":"print","value":"0021-1265"},{"type":"electronic","value":"1863-4362"}],"subject":[],"published":{"date-parts":[[2023,4,12]]},"assertion":[{"value":"25 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study followed the Declaration of Helsinki and the questionnaire and methodology for this study was approved by Polish Mother\u2019s Memorial Hospital Research Institute (PMMHRI-BCO.16\/2019).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All participants received and signed a written informed consent before entering a study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}